USP17L25 Gene - Ubiquitin Specific Peptidase 17 Like Family Member 25

A member of the deubiquitinating enzyme family with potential roles in cell proliferation and cancer biology

Gene Information Card

Symbol USP17L25
Full Name Ubiquitin Specific Peptidase 17 Like Family Member 25
Gene Type protein-coding
Chromosomal Location 8p23.1
NCBI Gene ID 100287485 ncbi.nlm.nih.gov/gene/100287485
Ensembl ID ENSG00000227372
UniProt ID A6NKQ8
OMIM ID Not available
HGNC ID 44470
Aliases USP17L25, ubiquitin specific peptidase 17-like family member 25

Description

USP17L25 is a protein-coding gene that belongs to the ubiquitin-specific peptidase (USP) family. It encodes a deubiquitinating enzyme that removes ubiquitin from target proteins, thereby regulating various cellular processes including cell cycle progression, apoptosis, and immune responses. The gene is located on chromosome 8p23.1, a region known for copy number variations and associations with cancer susceptibility. USP17L25 is part of a cluster of USP17-like genes that are often amplified in certain cancers, suggesting a potential role in tumorigenesis.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Cancer (general) Overexpression of USP17 family members has been linked to enhanced cell proliferation and tumor growth; USP17L25 may contribute similarly via deubiquitination of oncogenic substrates. Inferred from family member studies (e.g., USP17L2) in cancer cell lines; direct evidence for USP17L25 is limited.
Inflammatory diseases USP17 family members modulate NF-kB signaling, potentially affecting inflammatory responses. Inferred from functional studies of USP17 in immune cells; direct evidence for USP17L25 is lacking.

Expression Profile

Tissue Expression
Tissue nTPM level
Testis Not available Low expression (based on RNA-seq data from GTEx, if available; otherwise inferred from family members)
Lung Not available Moderate expression (inferred from USP17 family)
Liver Not available Low expression (inferred from USP17 family)
Cell Line Expression
Cell Line nTPM Notes
HeLa Not available USP17 family members are expressed in cervical cancer cell lines; specific data for USP17L25 not available.
HEK293 Not available Commonly used for overexpression studies; endogenous expression may be low.
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
No specific variants reported Not applicable Not applicable No curated mutations in ClinVar or COSMIC for USP17L25.
Mutation functional classification

Loss of Function (LOF)

No data available; loss-of-function mutations have not been characterized for USP17L25.

Gain of Function (GOF)

No data available; gain-of-function mutations have not been reported.

Dominant Negative (DN)

No data available; dominant-negative effects have not been described.

Gene Ontology (GO)

• cysteine-type peptidase activity • ubiquitin-specific protease activity
• proteolysis • ubiquitin-dependent protein catabolic process

Pathways

• Ubiquitin-proteasome system
• Deubiquitination pathway

Protein Summary

The USP17L25 protein is a deubiquitinating enzyme that cleaves ubiquitin from target proteins, thereby preventing their degradation by the proteasome. It contains a peptidase C19 domain characteristic of ubiquitin-specific proteases. The protein is predicted to localize to the cytoplasm and nucleus. Its exact substrates are unknown, but based on homology to other USP17 family members, it may regulate cell cycle regulators and oncoproteins. The protein is encoded by a gene located in a region of chromosome 8 that is frequently amplified in cancers, suggesting a potential oncogenic role.

Related Products

Product name Cat.No. Species Gene ID
USP17L25 Knockout HEK293 Cell Line EDJ-KQ16068 Human 728373 Details Get a Quote
USP17L25 Knockout A-549 Cell Line EDJ-KQ47181 Human 728373 Details Get a Quote
USP17L25 Knockout HCT 116 Cell Line EDJ-KQ47182 Human 728373 Details Get a Quote
USP17L25 Knockout HeLa Cell Line EDJ-KQ47183 Human 728373 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: